Skip to main content
Clinical Trials/NCT04189575
NCT04189575
Active, Not Recruiting
N/A

A Text Messaging (SMS) Intervention to Improve Adherence to Stimulant Medication in Adults With ADHD in the Primary Care Setting

Massachusetts General Hospital1 site in 1 country117 target enrollmentMay 24, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Attention Deficit/Hyperactivity Disorder
Sponsor
Massachusetts General Hospital
Enrollment
117
Locations
1
Primary Endpoint
Adherence to Stimulants
Status
Active, Not Recruiting
Last Updated
3 years ago

Overview

Brief Summary

This study will assess the efficacy of the text messaging (SMS-based) disease management intervention to improve adherence to stimulants in adults with Attention Deficit/Hyperactivity Disorder (ADHD) within the Partners primary and psychiatry care settings.

Participants in the study will receive customized text messages twice a day, every day, for a duration of 9 months. The text messages will include reminders to adhere to the individualized medication regimen, reminders to call their clinician for a prescription refill followed by reminders to pick up medication from the pharmacy, and educational reminders about ADHD and its treatment

Registry
clinicaltrials.gov
Start Date
May 24, 2018
End Date
December 2023
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Joseph Biederman, MD

Chief of the Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD

Massachusetts General Hospital

Eligibility Criteria

Inclusion Criteria

  • Male and female adults ages 18-55 years
  • Receipt of a prescription for stimulant medication by their primary care physician or psychiatrist
  • Proficient in English
  • Has a cellular phone with text messaging capabilities and is interested in and willing to receive free of charge planned text messages

Exclusion Criteria

  • Investigator and his/her immediate family
  • Unwilling/unable to comply with study procedures

Outcomes

Primary Outcomes

Adherence to Stimulants

Time Frame: 9 months

Adherence will be analyzed using the timeliness of stimulant medication prescription renewals over the 9 month period.

Study Sites (1)

Loading locations...

Similar Trials